| | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $732,978 ) |
| 2024 | 2024 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803 | NEW CASTLE | USA | Cancer Control | 000 | 11 | 7/31/2024 | NON-COMPETING CONTINUATION | $732,978 |
|
| Issue Date FY: 2023 ( Subtotal = $607,598 ) |
| 2023 | 2023 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803 | NEW CASTLE | USA | Cancer Control | 001 | 10 | 7/26/2023 | NON-COMPETING CONTINUATION | $607,598 |
| 2023 | 2022 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803 | NEW CASTLE | USA | Cancer Control | 000 | 9 | 7/20/2023 | NON-COMPETING CONTINUATION | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $780,572 ) |
| 2022 | 2022 | NEMOURS FOUNDATION, THE | 1600 ROCKLAND RD | WILMINGTON | DE | 19803 | NEW CASTLE | USA | Cancer Control | 000 | 9 | 8/1/2022 | NON-COMPETING CONTINUATION | $780,572 |
|
| Issue Date FY: 2021 ( Subtotal = $719,191 ) |
| 2021 | 2021 | NEMOURS FOUNDATION, THE | 1600 ROCKLAND RD | WILMINGTON | DE | 19803 | NEW CASTLE | USA | Cancer Control | 001 | 8 | 8/12/2021 | NON-COMPETING CONTINUATION | $719,191 |
| 2021 | 2020 | NEMOURS FOUNDATION, THE | 1600 ROCKLAND RD | WILMINGTON | DE | 19803 | NEW CASTLE | USA | Cancer Control | 000 | 7 | 4/29/2021 | NON-COMPETING CONTINUATION | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $667,352 ) |
| 2020 | 2020 | NEMOURS FOUNDATION, THE | 1600 ROCKLAND RD | WILMINGTON | DE | 19803 | NEW CASTLE | USA | Cancer Control | 002 | 7 | 8/6/2020 | NON-COMPETING CONTINUATION | $667,352 |
| 2020 | 2019 | NEMOURS FOUNDATION, THE | 1600 ROCKLAND RD | WILMINGTON | DE | 19803 | NEW CASTLE | USA | Cancer Control | 001 | 6 | 4/8/2020 | COMPETING CONTINUATION | $111,548 |
| 2020 | 2018 | NEMOURS FOUNDATION, THE | 1600 ROCKLAND RD | WILMINGTON | DE | 19803 | NEW CASTLE | USA | Cancer Treatment Research | 000 | 5 | 4/8/2020 | NON-COMPETING CONTINUATION | -$111,548 |
|
| Issue Date FY: 2019 ( Subtotal = $793,179 ) |
| 2019 | 2019 | NEMOURS FOUNDATION, THE | 1600 ROCKLAND RD | WILMINGTON | DE | 19803 | NEW CASTLE | USA | Cancer Control | 001 | 6 | 8/29/2019 | COMPETING CONTINUATION | $793,179 |
| 2019 | 2018 | NEMOURS FOUNDATION, THE | 1600 ROCKLAND RD | WILMINGTON | DE | 19803 | NEW CASTLE | USA | Cancer Treatment Research | 000 | 5 | 5/24/2019 | NON-COMPETING CONTINUATION | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $666,396 ) |
| 2018 | 2018 | NEMOURS FOUNDATION, THE | 1600 ROCKLAND RD | WILMINGTON | DE | 19803 | NEW CASTLE | USA | Cancer Treatment Research | 000 | 5 | 8/10/2018 | NON-COMPETING CONTINUATION | $666,396 |
|
| Issue Date FY: 2017 ( Subtotal = $388,215 ) |
| 2017 | 2017 | NEMOURS FOUNDATION, THE | 1600 ROCKLAND RD | WILMINGTON | DE | 19803 | NEW CASTLE | USA | Cancer Treatment Research | 000 | 4 | 7/27/2017 | NON-COMPETING CONTINUATION | $388,215 |
|
| Issue Date FY: 2016 ( Subtotal = $992,500 ) |
| 2016 | 2016 | ALFRED I DUPONT HOSP FOR CHILD NCC-W OF THE NEMOURS FDN | 1600 ROCKLAND ROAD | WILMINGTON | DE | 19803 | NEW CASTLE | USA | Cancer Treatment Research | 000 | 3 | 8/1/2016 | NON-COMPETING CONTINUATION | $992,500 |
|
| Issue Date FY: 2015 ( Subtotal = $992,500 ) |
| 2015 | 2015 | ALFRED I DUPONT HOSP FOR CHILD NCC-W OF THE NEMOURS FDN | 1600 ROCKLAND ROAD | WILMINGTON | DE | 19803 | NEW CASTLE | USA | Cancer Treatment Research | 000 | 2 | 8/24/2015 | NON-COMPETING CONTINUATION | $930,000 |
| 2015 | 2015 | ALFRED I DUPONT HOSP FOR CHILD NCC-W OF THE NEMOURS FDN | 1600 ROCKLAND ROAD | WILMINGTON | DE | 19803 | NEW CASTLE | USA | Cancer Treatment Research | 001 | 2 | 9/10/2015 | NON-COMPETING CONTINUATION | $62,500 |
|
| Issue Date FY: 2014 ( Subtotal = $1,040,214 ) |
| 2014 | 2014 | ALFRED I DUPONT HOSP FOR CHILD NCC-W OF THE NEMOURS FDN | 1600 ROCKLAND ROAD | WILMINGTON | DE | 19803 | NEW CASTLE | USA | Cancer Treatment Research | 000 | 1 | 7/30/2014 | NEW | $930,000 |
| 2014 | 2014 | ALFRED I DUPONT HOSP FOR CHILD NCC-W OF THE NEMOURS FDN | 1600 ROCKLAND ROAD | WILMINGTON | DE | 19803 | NEW CASTLE | USA | Cancer Treatment Research | 001 | 1 | 9/18/2014 | NEW | $110,214 |
|
|